Ovarian Cancer Market by Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, and Primary Peritoneal Carcinoma), by Cancer Stage (Stage I, Stage II, Stage III, and Stage IV), by Diagnostics (Physical Examination, Biopsy, Blood Tests, Human Chorionic Gonadotropin (hCG) test, ultrasound, MRI, PET, and CT scans), and by Treatment (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, and Surgery): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Global ovarian cancer market expected to generate revenue of around USD 4.01 billion by end of 2024, growing at a CAGR of around 11.82% between 2018 and 2024. Ovaries are located on each side of the uterus and are a part of the female reproductive system. Ovaries produce ovum and female hormones progesterone and estrogen.

11-Aug-2018 | Number of pages: 110 | Report Code: ZMR-3037 | Report Format : | Status : Published

Analysis

Ovaries are located on each side of the uterus and are a part of the female reproductive system. Ovaries produce ovum and female hormones progesterone and estrogen. These female hormones manage the menstrual cycle along with influencing the development of female body characteristics. In normal conditions, human cells undergo division and fusion that results in the formation of new cells. New cells take the place of old or damaged cells. However, this process is disturbed when cancer develops. In cancer, the old or damaged cells survive and new cells keep appearing. This abnormality could lead to the formation of a tumor, a mass of cells. Ovarian cancer is a disease which involves the abnormal or cancerous growth of the cells in the ovaries. There are four major types of ovarian cancer: Epithelial ovarian cancer, Borderline tumors, Germ cell ovarian cancer, and Sex-cord stromal cell cancer. The cancer types are determined based on the location of the ovarian cells where the cancerous growth starts. After starting from ovaries, ovarian cancer spreads to the pelvis and abdomen region. Ovarian cancer is virtually undetectable when it is in the ovaries.

According to World Cancer Research Fund International, ovarian cancer comes in at the eighteenth number on the list of most common cancer and on the seventh number in the list of common cancer in women. The highest occurrence of ovarian cancer is found in North America and Europe. As per the estimates are given by American Cancer Society for the year 2018, in the United States around 22,400 women are expected to receive ovarian cancer diagnosis and around 14,070 ovarian cancer deaths will occur. Ovarian cancer causes more deaths than any other female reproductive system cancers. Ovarian cancer is the fifth leading cause of death due to cancer in women. About 1 in 78 women are at the risk of getting ovarian cancer. Women in the age group of 50 to 60 years are at a higher risk of getting ovarian cancer.

Global Ovarian Cancer Market

The strongest risk factors that can cause ovarian cancer are acquired genetic changes, genetic mutations called BRCA1 or BRCA2, old age, obesity, not having a full-term pregnancy, using fertility treatment, hormone therapy post menopause, and PTEN tumor hamartoma syndrome.

Factors such as increasing geriatric population of women rise in ovarian cancer cases, availability of new drugs and therapies, increase in healthcare expenditure, and increased government funding are expected to boost the growth of ovarian cancer market. However, availability of generic drugs and patent expiration of branded drugs can act as a restraint in the growth of the ovarian cancer market. The lack of precise diagnostic techniques for ovarian cancer in the early stages can also have a negative impact on the global ovarian cancer market.

On the basis of the type the ovarian cancer market has been divided into epithelial ovarian tumors, ovarian germ cell tumors, ovarian stromal tumors, and primary peritoneal carcinoma. On the basis of the cancer stage, the market is segmented into Stage I, Stage II, Stage III, and Stage IV. On the basis of diagnostics, the market divided into the physical examination, biopsy, blood tests, Human Chorionic Gonadotropin (HCG) test, ultrasound, MRI (Magnetic resonance imaging), PET (Positron emission tomography), and CT scans. On the basis of treatment, the market divided into chemotherapy, targeted therapy, radiation therapy, immunotherapy, hormonal therapy, and surgery. In the forecast period, the diagnostic segment will dominate the global market as ovarian cancer is most chemosensitive cancer.

North America will be the dominant region during the forecast period. Increasing prevalence of ovarian cancer in the region and availability of latest diagnostic methods are the factors that will boost the ovarian cancer market in this region. Europe will be the second largest market. The Asia Pacific will grow at the fastest rate over the forecast period. Increasing healthcare expenditure and growing attention towards ovarian cancer diagnosis are the driving factors for the growth of the ovarian cancer market in this region. Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are expected to experience noticeable growth in the years to come.

Some of the key players in ovarian cancer market include Astra Zeneca Plc, Bristol Myers Squibb Company, Genentech Inc., Eli Lilly and Company, Novogen, Inc., GlaxoSmithKline Plc, Janssen Pharmaceuticals, Inc., Aetera Zenteris Inc., Boehringer Ingelheim GmbH, F. Hoffman-La Roche Ltd., and others.


Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.